IN2014CN00436A - - Google Patents

Info

Publication number
IN2014CN00436A
IN2014CN00436A IN436CHN2014A IN2014CN00436A IN 2014CN00436 A IN2014CN00436 A IN 2014CN00436A IN 436CHN2014 A IN436CHN2014 A IN 436CHN2014A IN 2014CN00436 A IN2014CN00436 A IN 2014CN00436A
Authority
IN
India
Prior art keywords
protein
prepared
glu
preparing
lauroyl
Prior art date
Application number
Other languages
English (en)
Inventor
Daisuke Ejima
Haruna Sato
Kouhei Tsumoto
Masayo Date
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of IN2014CN00436A publication Critical patent/IN2014CN00436A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN436CHN2014 2011-06-23 2012-06-25 IN2014CN00436A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011139837 2011-06-23
PCT/JP2012/066121 WO2012176919A1 (ja) 2011-06-23 2012-06-25 免疫グロブリン折りたたみ構造を持つタンパク質と、サブユニット構造となりうるタンパク質とを融合させた単量体タンパク質からなる多量体タンパク質の調製方法

Publications (1)

Publication Number Publication Date
IN2014CN00436A true IN2014CN00436A (ko) 2015-04-03

Family

ID=47422745

Family Applications (1)

Application Number Title Priority Date Filing Date
IN436CHN2014 IN2014CN00436A (ko) 2011-06-23 2012-06-25

Country Status (7)

Country Link
US (1) US10308969B2 (ko)
EP (1) EP2725104B1 (ko)
JP (1) JP5858251B2 (ko)
CN (2) CN107365388B (ko)
IL (1) IL229682B (ko)
IN (1) IN2014CN00436A (ko)
WO (1) WO2012176919A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN00436A (ko) 2011-06-23 2015-04-03 Ajinomoto Kk

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2197210T3 (es) 1994-11-30 2004-01-01 Ajinomoto Co., Inc. Agente antitrombotico y anticuerpos monoclonales contra el factor von willebrand.
US7144991B2 (en) * 1999-06-07 2006-12-05 Aletheon Pharmaceuticals, Inc. Streptavidin expressed gene fusions and methods of use thereof
BRPI0407911A (pt) 2003-03-07 2006-02-14 Ajinomoto Kk método para produzir uma transglutaminase ativa microbiana a partir de uma pró-transglutaminase microbiana, metaloprotease neutra de actionomicetos, molécula de ácido nucleico, e, método para produzir uma metaloprotease neutra de actinomicetos
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
WO2005103278A1 (ja) 2004-04-20 2005-11-03 Ajinomoto Co., Inc. タンパク質の製造法
US8669045B2 (en) 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
KR101162049B1 (ko) 2007-02-15 2012-07-04 아지노모토 가부시키가이샤 디설파이드 결합 도입 트랜스글루타미나제
JP5168604B2 (ja) * 2008-05-08 2013-03-21 味の素株式会社 タンパク質のリフォールディング方法
WO2010101256A1 (ja) 2009-03-06 2010-09-10 味の素株式会社 放線菌由来の耐熱性トランスグルタミナーゼ
ES2544284T3 (es) 2010-02-26 2015-08-28 Ajinomoto Co., Inc. Composición que inactiva virus que contiene un compuesto de bajo peso molecular y arginina
IN2014CN00436A (ko) 2011-06-23 2015-04-03 Ajinomoto Kk

Also Published As

Publication number Publication date
JPWO2012176919A1 (ja) 2015-02-23
CN103608463A (zh) 2014-02-26
CN107365388B (zh) 2021-05-14
IL229682B (en) 2018-04-30
EP2725104B1 (en) 2019-08-21
JP5858251B2 (ja) 2016-02-10
EP2725104A4 (en) 2014-11-12
US10308969B2 (en) 2019-06-04
WO2012176919A1 (ja) 2012-12-27
IL229682A0 (en) 2014-01-30
US20140099672A1 (en) 2014-04-10
EP2725104A1 (en) 2014-04-30
CN107365388A (zh) 2017-11-21

Similar Documents

Publication Publication Date Title
GEP20237513B (en) Improved methods for enhancing antibody productivity in mammalian cell culture and minimizing aggregation during downstream, formulation processes and stable antibody formulations obtained thereof
SG195306A1 (en) Purification of biological products by constrained cohydration chromatography
BR112013026883A2 (pt) Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica
CL2016000333A1 (es) Proteínas de unión a il-1
AR091098A1 (es) ANTICUERPOS E INMUNOCONJUGADOS CONTRA Ly6E Y METODOS DE USO
EA201490815A1 (ru) Составы этанерцепта, стабилизированные с помощью аминокислот
EA201991976A1 (ru) Метаболически оптимизированная клеточная культура
BR112013023006A2 (pt) formulações de suspensões não aquosas de anticorpos de alta concentração e viscosidade reduzida
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
ZA201403785B (en) Compositions and methods for modifying a predetermined target nucleic acid sequence
NZ630848A (en) Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
EP2928924A4 (en) HIV-1 ENV BINDING ANTIBODIES, FUSION PROTEINS AND METHODS OF USE
AR088322A1 (es) Anticuerpos anti-htra1 y metodos de uso
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins
EA201400993A1 (ru) Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения
EA201400709A1 (ru) Молекула биспецифического антитела
UA114902C2 (uk) Виділене антитіло, яке зв'язує парний спіральний філамент-тау (псф-тау), та фармацевтична композиція, що містить таке антитіло
BR112015004467A2 (pt) método para controlar a heterogeneidade de proteínas
NZ629204A (en) Anti-vla1 (cd49a) antibody pharmaceutical compositions
MY181513A (en) Cell culture compositions and methods for polypeptide production
MX356454B (es) Una formulacion enzimatica liquida y un proceso para su preparacion.
NZ713602A (en) Method for refining protein including self-cutting cassette and use thereof
EP2492689B8 (en) Detection of antibodies using an improved immune complex (IC) ELISA
MX2014015088A (es) Anticuerpos anti-tofacitinib y usos de los mismos para monitorear farmacos.
IN2014DN06660A (ko)